BIA
TXG icon

Bell Investment Advisors’s 10x Genomics TXG Stock Holding History

Bell Investment Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Hold
61
– – ﹤0.01% 1283
2026
Q1 		$1.3K Hold
61
– – ﹤0.01% 1472
2025
Q4 		$995 Sell
61
-14
-19% -$211 ﹤0.01% 1549
2025
Q3 		$877 Hold
75
– – ﹤0.01% 1586
2025
Q2 		$869 Sell
75
-97
-56% -$884 ﹤0.01% 1633
2025
Q1 		$1.5K Sell
172
-50
-23% -$630 ﹤0.01% 1414
2024
Q4 		$3.19K Buy
222
+110
+98% +$1.74K ﹤0.01% 1145
2024
Q3 		$2.53K Buy
112
+76
+211% +$1.57K ﹤0.01% 1251
2024
Q2 		$701 Sell
36
-6
-14% -$157 ﹤0.01% 1706
2024
Q1 		$1.58K Sell
42
-24
-36% -$1.05K ﹤0.01% 1445
2023
Q4 		$3.69K Sell
66
-38
-37% -$1.65K ﹤0.01% 1042
2023
Q3 		$4.29K Sell
104
-19
-15% -$988 ﹤0.01% 888
2023
Q2 		$6.87K Buy
123
+9
+8% +$487 ﹤0.01% 663
2023
Q1 		$6.36K Hold
114
– – ﹤0.01% 671
2022
Q4 		$4.15K Buy
114
+62
+119% +$2.03K ﹤0.01% 905
2022
Q3 		$1K Buy
52
+34
+189% +$1.29K ﹤0.01% 1608
2022
Q2 		$1K Buy
+18
New +$934 ﹤0.01% 1634
2021
Q4 		$1K Sell
10
-33
-77% -$5.05K ﹤0.01% 1641
2021
Q3 		$6K Buy
+43
New +$7.38K ﹤0.01% 670

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bell Investment Advisors's TXG Position: Q2 2026 in Review

Bell Investment Advisors held its 10x Genomics (TXG) position steady in Q2 2026 at 61 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

Bell Investment Advisors first reported a position in TXG in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.87K in Q2 2023. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bell Investment Advisors held 61 shares of 10x Genomics worth $2.34K as of Q2 2026.
  • Bell Investment Advisors left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1283 holding.
  • Bell Investment Advisors first reported a position in 10x Genomics in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's 10x Genomics position peaked at $6.87K in Q2 2023.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.